Amgen Inc (AMGN): who owns it and who trades it
As of Nov 12, 2026, AMGN insiders reported 12 open-market sales worth $26.7M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Esteban Santos (Vice president), with $20.8M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Amgen
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns AMGN
3,132 funds and institutions reported AMGN shares worth $161B at the end of Q2 2026, about 83% of the company. The largest holder is BlackRock, Inc. with 9.1%.
Funds and institutions (13F) 83%Everyone else 17%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 49.36M | 9.15% | $17.9B | +5% |
| Vanguard Capital Management LLC | 35.25M | 6.53% | $12.8B | +1% |
| State Street Corp | 30.56M | 5.66% | $11.1B | No change |
| Capital World Investors | 29.08M | 5.39% | $10.5B | -1% |
| Invesco Ltd. | 16.32M | 3.02% | $5.9B | +257% |
| Geode Capital Management, LLC | 15.70M | 2.91% | $5.7B | +2% |
| Charles Schwab Investment Management Inc | 15.03M | 2.79% | $5.4B | +18% |
| Vanguard Portfolio Management LLC | 14.85M | 2.75% | $5.4B | +2% |
| Morgan Stanley | 13.65M | 2.53% | $4.9B | -14% |
| Wells Fargo & Company | 7.24M | 1.34% | $2.6B | +2% |
| Primecap Management Co | 6.76M | 1.25% | $2.4B | -24% |
| Capital Research Global Investors | 6.27M | 1.16% | $2.3B | -10% |
| Northern Trust Corp | 6.20M | 1.15% | $2.2B | -0% |
| Norges Bank | 5.63M | 1.04% | $2B | – |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.39M | 1.00% | $2B | +13% |
| Bank of America Corp | 5.06M | 0.94% | $1.8B | -1% |
| Royal Bank of Canada | 4.33M | 0.80% | $1.6B | -3% |
| Goldman Sachs Group Inc | 4.13M | 0.77% | $1.5B | -2% |
| T. Rowe Price Associates | 3.96M | 0.73% | $1.4B | +112% |
| Amundi | 3.89M | 0.72% | $1.4B | +15% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, AMGN insiders reported $0 of open-market purchases and $26.7M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Rachna Khosla | Vice president | Sale | 1,252 | $416.43 | $521K | Form 4 |
| Aug 11, 2026 | Rachna Khosla | Vice president | Sale | 2,000 | $412.57 | $825K | Form 4 |
| Aug 6, 2026 | Derek Miller | Vice president | Sale | 2,069 | $402.54 | $833K | Form 4 |
| Aug 6, 2026 | Derek Miller | Vice president | Sale | 1,821 | $402.54 | $733K | Form 4 |
| Aug 6, 2026 | Nancy A. Grygiel | Vice president | Sale | 1,000 | $402.16 | $402K | Form 4 |
| Aug 6, 2026 | Nancy A. Grygiel | Vice president | Sale | 1,970 | $402.16 | $792K | Form 4 |
| May 4, 2026 | Nancy A. Grygiel | Vice president | Sale | 1,237 | $323.73 | $400K | Form 4 |
| Feb 26, 2026 | Esteban Santos | Vice president | Sale | 24,291 | $379.12 | $9.2M | Form 4 |
| Feb 26, 2026 | Esteban Santos | Vice president | Sale | 30,501 | $379.12 | $11.6M | Form 4 |
| Feb 19, 2026 | Matthew C. Busch | Vice president | Sale | 1,000 | $375.79 | $376K | Form 4 |
| Nov 20, 2025 | Nancy A. Grygiel | Vice president | Sale | 1,639 | $337.26 | $553K | Form 4 |
| Nov 20, 2025 | Nancy A. Grygiel | Vice president | Sale | 1,500 | $337.26 | $506K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Esteban Santos | EVP, Operations | – | $20.8M | Feb 26, 2026 |
| Nancy A. Grygiel | SVP & CCO | – | $2.7M | Aug 6, 2026 |
| Derek Miller | SVP, Human Resources | – | $1.6M | Aug 6, 2026 |
| Rachna Khosla | SVP, Business Development | – | $1.3M | Aug 13, 2026 |
| Matthew C. Busch | VP, Finance & CAO | – | $376K | Feb 19, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
AMGN short interest
Low short interest. 2.3% of AMGN shares are sold short: about 1 share in 43. Over the last 12 reports the number of shares short went up 2%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 12.59M AMGN shares were sold short, 2.3% of the shares outstanding, down 5.9% from the report before. At the average daily volume of 2.53M shares, buying them all back would take about 5.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 12.59M | 2.33% | -6% | 2.53M | 5.0 |
| Oct 15, 2026 | 13.38M | 2.47% | -5% | 2.69M | 5.0 |
| Sep 30, 2026 | 14.03M | 2.59% | -0% | 3.42M | 4.1 |
| Sep 15, 2026 | 14.06M | 2.60% | +8% | 2.85M | 4.9 |
| Aug 31, 2026 | 12.97M | 2.40% | +8% | 2.31M | 5.6 |
| Aug 14, 2026 | 12.04M | 2.23% | -9% | 2.77M | 4.3 |
| Jul 31, 2026 | 13.28M | 2.46% | +3% | 2.58M | 5.2 |
| Jul 15, 2026 | 12.85M | 2.38% | -0% | 2.02M | 6.4 |
| Jun 30, 2026 | 12.87M | 2.38% | +5% | 3.27M | 3.9 |
| Jun 15, 2026 | 12.20M | 2.26% | +3% | 2.97M | 4.1 |
| May 29, 2026 | 11.85M | 2.20% | -4% | 2.38M | 5.0 |
| May 15, 2026 | 12.29M | 2.28% | -5% | 2.88M | 4.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded AMGN
Since Nov 16, 2024, 15 members of Congress reported 15 purchases and 17 sales of AMGN. The latest was a sale by David J. Taylor on Nov 3, 2026, reported Nov 12, 2026.
Purchases 15Sales 17
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Nov 12, 2026 | Report |
| Oct 15, 2026 | Sheldon Whitehouse (D-RI) | Sale | $15K–$50K | Spouse | Nov 2, 2026 | Report |
| Sep 22, 2026 | David J. Taylor (R-OH) | Purchase | $1K–$15K | Self | Oct 1, 2026 | Report |
| Aug 26, 2026 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Sep 5, 2026 | Report |
| Aug 12, 2026 | Sheldon Whitehouse (D-RI) | Partial sale | $1K–$15K | Spouse | Sep 2, 2026 | Report |
| Jun 5, 2026 | David J. Taylor (R-OH) | Purchase | $1K–$15K | Self | Jun 12, 2026 | Report |
| Apr 17, 2026 | Maria Elvira Salazar (R-FL) | Sale | $15K–$50K | Self | May 8, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Sale | $15K–$50K | Self | Jul 21, 2026 | Report |
| Mar 24, 2026 | Maria Elvira Salazar (R-FL) | Purchase | $15K–$50K | Self | Apr 21, 2026 | Report |
| Feb 26, 2026 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Mar 6, 2026 | Report |
| Jan 29, 2026 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Feb 2, 2026 | Report |
| Jan 16, 2026 | David J. Taylor (R-OH) | Purchase | $1K–$15K | Self | Feb 2, 2026 | Report |
| Dec 3, 2025 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Dec 5, 2025 | Report |
| Oct 24, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | Oct 28, 2025 | Report |
| Sep 25, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Oct 22, 2025 | Report |
| Sep 11, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | Sep 27, 2025 | Report |
| Sep 4, 2025 | Sheldon Whitehouse (D-RI) | Sale | $1K–$15K | Self | Oct 3, 2025 | Report |
| Jun 24, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 6, 2025 | Cliff Bentz (R-OR) | Purchase | $1K–$15K | Spouse | Jul 9, 2025 | Report |
| May 14, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | May 19, 2025 | Report |
| May 12, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| May 5, 2025 | Marjorie Greene (GA) | Purchase | $1K–$15K | Self | May 6, 2025 | Report |
| Apr 16, 2025 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Child | May 9, 2025 | Report |
| Apr 16, 2025 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Self | May 9, 2025 | Report |
| Apr 15, 2025 | Tommy Tuberville (R-AL) | Sale | $15K–$50K | Joint | May 15, 2025 | Report |
| Apr 11, 2025 | Jefferson Shreve (R-IN) | Purchase | $15K–$50K | Self | May 8, 2025 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | May 8, 2025 | Report |
| Feb 24, 2025 | Jefferson Shreve (R-IN) | Purchase | $15K–$50K | Self | Mar 9, 2025 | Report |
| Feb 11, 2025 | Daniel Meuser (R-PA) | Sale | $1K–$15K | Spouse | Aug 20, 2025 | Report |
| Jan 6, 2025 | Emily Randall (D-WA) | Sale | $1K–$15K | Spouse | Feb 11, 2025 | Report |
| Dec 6, 2024 | Virginia Foxx (R-NC) | Purchase | $1K–$15K | Self | Jan 6, 2025 | Report |
| Nov 19, 2024 | Julia Letlow (R-LA) | Sale | $1K–$15K | Self | Jan 13, 2026 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Amgen company events
Amgen filed 11 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, cyberattack). The latest was on Nov 3, 2026.
- Nov 3, 2026ResultsReleased financial results. Filing
- Oct 27, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jul 31, 2026CyberattackIn July 2026, Amgen Inc. identified unauthorized activity involving data stored in cloud environments hosted by third-party cloud service providers. Filing
- May 20, 2026VoteReported shareholder vote results. Filing
- May 19, 2026LeadershipAmgen Inc. publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026. Filing
- Apr 30, 2026ResultsReleased financial results. Filing
- Apr 22, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
- Feb 19, 2026AgreementSigned an important agreement. Filing
- Feb 3, 2026ResultsReleased financial results. Filing
- Jan 30, 2026AgreementEnded an important agreement. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
How Amgen makes money
Prolia brought in 12% of Amgen's revenue ($4.4B of $36.8B) in 2025. Repatha was next, at 8%.
By product or service, 2025
By region, 2025
From Amgen's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 13, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money
Amgen financials
Famous investors that hold AMGN
4 of the 50 well-known investors we track reported holding AMGN in their latest 13F filing. The largest position is Ken Fisher's, worth $713M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Fisher · Fisher Asset Management | Q3 2026 | 1.69M | $713M | 0.2% | +6% |
| Ken Griffin · Citadel Advisors | Q2 2026 | 703,984 | $255M | 0.1% | +281% |
| Israel Englander · Millennium Management | Q2 2026 | 79,344 | $28.7M | 0.0% | -66% |
| Ray Dalio · Bridgewater Associates | Q2 2026 | 21,869 | $7.9M | 0.0% | +48% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Amgen Inc (AMGN) stock
Who owns the most AMGN stock?
The largest reported owner of Amgen Inc (AMGN) is BlackRock, Inc., with 9.1% of the company. In total, 3,132 funds and institutions reported holding AMGN at the end of Q2 2026, together about 83% of the shares. See the largest owners.
Are AMGN insiders buying or selling?
In the last 12 months, AMGN insiders reported no open-market purchases and 12 sales worth $26.7M. The latest trade was on Aug 13, 2026. See every trade.
What is the short interest in AMGN?
As of Oct 30, 2026, 12.59M AMGN shares were sold short, 2.3% of the shares outstanding, down 5.9% from the report before. At the average daily volume of 2.53M shares, buying them all back would take about 5.0 trading days (days to cover). See the history.
Have members of Congress traded AMGN?
Yes. 15 members of Congress reported 15 purchases and 17 sales of AMGN since Nov 16, 2024. The latest was reported on Nov 12, 2026. See the trades.
How does Amgen make money?
Prolia brought in 12% of Amgen's revenue ($4.4B of $36.8B) in 2025. Repatha was next, at 8%. See the full split.
Which famous investors hold AMGN?
4 of the 50 well-known investors we track reported AMGN in their latest 13F filing, including Ken Fisher, Ken Griffin, Israel Englander. The largest position is worth $713M. See all holders.
Executive pay
Amgen's chief executive was paid a total of $24.7M for the year ended Dec 31, 2025, up 1% from $24.4M the year before. In the last 12 months, Amgen's executives and directors bought no stock on the open market and sold $26.7M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.